Showing 1 - 6 results of 6 for search 'Shinji L Okitsu', query time: 0.03s Refine Results
  1. 1
    Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis

    Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis by Huihua Ding, Yiwei Shen, Cheng Lin, Ling Qin, Shijun He, Min Dai, Shinji L. Okitsu, Julie A. DeMartino, Qiang Guo, Nan Shen

    Published 2022-03-01
    Get full text
    Article
  2. 2
    A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers.

    A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers. by Blaise Genton, Gerd Pluschke, Lukas Degen, Andreas R Kammer, Nicole Westerfeld, Shinji L Okitsu, Sandro Schroller, Penelope Vounatsou, Markus M Mueller, Marcel Tanner, Rinaldo Zurbriggen

    Published 2007-10-01
    Get full text
    Article
  3. 3
    A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.

    A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial. by Shinji L Okitsu, Olivier Silvie, Nicole Westerfeld, Marija Curcic, Andreas R Kammer, Markus S Mueller, Robert W Sauerwein, John A Robinson, Blaise Genton, Dominique Mazier, Rinaldo Zurbriggen, Gerd Pluschke

    Published 2007-12-01
    Get full text
    Article
  4. 4
    Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases

    Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases by Thomas Clarke, Pan Du, Satyendra Kumar, Shinji L. Okitsu, Mark Schuette, Qi An, Jinyang Zhang, Evgeni Tzvetkov, Mark A. Jensen, Timothy B. Niewold, Elise M. N. Ferre, Julie Nardone, Michail S. Lionakis, Jaromir Vlach, Julie DeMartino, Andrew T. Bender

    Published 2023-02-01
    Get full text
    Article
  5. 5
    Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.

    Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial. by Fiona M. Thompson, David W. Porter, Shinji L. Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L. Williams, Robert Sinden, Sarah C. Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V. S. Hill

    Published 2011-01-01
    Get full text
    Article
  6. 6
    Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

    Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial. by Fiona M Thompson, David W Porter, Shinji L Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L Williams, Robert Sinden, Sarah C Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V S Hill

    Published 2008-01-01
    Get full text
    Article

Search Tools: